Cargando…

Assessment of C-Reactive Protein Level in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma Patient

BACKGROUND: Potentially malignant disorders are highly prevalent in India. In this study, we assessed C-reactive protein (CRP) levels in patients with oral submucous fibrosis (OSMF) and oral squamous cell carcinoma (OSCC). METHODOLOGY: Sixty-four patients (OSMF and OSCC) were undertaken and were cla...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Geeta, Kumar, Randhir, Salam, Sharib Abdus, Bhasin, Prashant, Tewari, Nishant Kumar, Yadav, Suman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375920/
https://www.ncbi.nlm.nih.gov/pubmed/34447194
http://dx.doi.org/10.4103/jpbs.JPBS_607_20
_version_ 1783740397489487872
author Sharma, Geeta
Kumar, Randhir
Salam, Sharib Abdus
Bhasin, Prashant
Tewari, Nishant Kumar
Yadav, Suman
author_facet Sharma, Geeta
Kumar, Randhir
Salam, Sharib Abdus
Bhasin, Prashant
Tewari, Nishant Kumar
Yadav, Suman
author_sort Sharma, Geeta
collection PubMed
description BACKGROUND: Potentially malignant disorders are highly prevalent in India. In this study, we assessed C-reactive protein (CRP) levels in patients with oral submucous fibrosis (OSMF) and oral squamous cell carcinoma (OSCC). METHODOLOGY: Sixty-four patients (OSMF and OSCC) were undertaken and were classified into 3 groups, OSMF patients (Group I, 34), OSCC (Group II, 30), and healthy controls (Group III, 26). Immunoturbidimetry method was used for the estimation of CRP levels. RESULTS: Maximum cases in Group I was seen in the age group 40–60 years (males-10, females-3), Group II in the age group 40–60 years (males-11, females-5) and Group III (males-5, females-6). The mean CRP level in Group I was 6.12 ± 4.5 mg/l, in Group II was 28.4 ± 21.5 mg/l, and in Group III was 3.15 ± 2.19 mg/l. The difference was significant (P < 0.05). CONCLUSION: Authors found that OSMF and oral cancer patients had increased CRP levels as compared to healthy subjects.
format Online
Article
Text
id pubmed-8375920
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-83759202021-08-25 Assessment of C-Reactive Protein Level in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma Patient Sharma, Geeta Kumar, Randhir Salam, Sharib Abdus Bhasin, Prashant Tewari, Nishant Kumar Yadav, Suman J Pharm Bioallied Sci Original Article BACKGROUND: Potentially malignant disorders are highly prevalent in India. In this study, we assessed C-reactive protein (CRP) levels in patients with oral submucous fibrosis (OSMF) and oral squamous cell carcinoma (OSCC). METHODOLOGY: Sixty-four patients (OSMF and OSCC) were undertaken and were classified into 3 groups, OSMF patients (Group I, 34), OSCC (Group II, 30), and healthy controls (Group III, 26). Immunoturbidimetry method was used for the estimation of CRP levels. RESULTS: Maximum cases in Group I was seen in the age group 40–60 years (males-10, females-3), Group II in the age group 40–60 years (males-11, females-5) and Group III (males-5, females-6). The mean CRP level in Group I was 6.12 ± 4.5 mg/l, in Group II was 28.4 ± 21.5 mg/l, and in Group III was 3.15 ± 2.19 mg/l. The difference was significant (P < 0.05). CONCLUSION: Authors found that OSMF and oral cancer patients had increased CRP levels as compared to healthy subjects. Wolters Kluwer - Medknow 2021-06 2021-06-05 /pmc/articles/PMC8375920/ /pubmed/34447194 http://dx.doi.org/10.4103/jpbs.JPBS_607_20 Text en Copyright: © 2021 Journal of Pharmacy and Bioallied Sciences https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Sharma, Geeta
Kumar, Randhir
Salam, Sharib Abdus
Bhasin, Prashant
Tewari, Nishant Kumar
Yadav, Suman
Assessment of C-Reactive Protein Level in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma Patient
title Assessment of C-Reactive Protein Level in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma Patient
title_full Assessment of C-Reactive Protein Level in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma Patient
title_fullStr Assessment of C-Reactive Protein Level in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma Patient
title_full_unstemmed Assessment of C-Reactive Protein Level in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma Patient
title_short Assessment of C-Reactive Protein Level in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma Patient
title_sort assessment of c-reactive protein level in oral submucous fibrosis and oral squamous cell carcinoma patient
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375920/
https://www.ncbi.nlm.nih.gov/pubmed/34447194
http://dx.doi.org/10.4103/jpbs.JPBS_607_20
work_keys_str_mv AT sharmageeta assessmentofcreactiveproteinlevelinoralsubmucousfibrosisandoralsquamouscellcarcinomapatient
AT kumarrandhir assessmentofcreactiveproteinlevelinoralsubmucousfibrosisandoralsquamouscellcarcinomapatient
AT salamsharibabdus assessmentofcreactiveproteinlevelinoralsubmucousfibrosisandoralsquamouscellcarcinomapatient
AT bhasinprashant assessmentofcreactiveproteinlevelinoralsubmucousfibrosisandoralsquamouscellcarcinomapatient
AT tewarinishantkumar assessmentofcreactiveproteinlevelinoralsubmucousfibrosisandoralsquamouscellcarcinomapatient
AT yadavsuman assessmentofcreactiveproteinlevelinoralsubmucousfibrosisandoralsquamouscellcarcinomapatient